Literature DB >> 3583850

Impact of neck node radioresponsiveness on the regional control probability in patients with oropharynx and pharyngolarynx cancers managed by definitive radiotherapy.

J P Bataini, J Bernier, C Jaulerry, F Brunin, D Pontvert, C Lave.   

Abstract

We reviewed a series of 1,666 patients with squamous cell carcinoma of the oropharynx and pharyngolarynx treated with definitive radiation therapy to determine whether or not radioresponsiveness of the metastatic neck nodes is a reliable indicator of their radiocurability. In a determined group of 708 patients with clinically positive neck nodes, only one third of the adenopathies (247/759) completely regressed at the completion of the treatment. At 6 months, only ten percent of the nodes remained palpable. Lymph node clearance rates and halving diameter times were tumor size-dependent. Node clearance rate was also influenced by the site of the primary lesion. The impact of various parameters, both intrinsic and extrinsic to the tumor behavior, is discussed. Neck control probability was significantly higher for complete responders. In this group, the ultimate node control was as good for adenopathies larger than 6 cm as for the smaller ones. Tumor control probability directly related to clearance rate following radiotherapy. Finally, therapeutic implications are derived for nodal dose adjustments and optimal applicability of radiosurgical combinations.

Entities:  

Mesh:

Year:  1987        PMID: 3583850     DOI: 10.1016/0360-3016(87)90093-9

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  7 in total

Review 1.  Management of cervical lymph nodes in patients with head and neck cancer.

Authors:  G B Snow; P Patel; C R Leemans; R Tiwari
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

Review 2.  Adaptive radiation therapy in head and neck cancer for clinical practice: state of the art and practical challenges.

Authors:  Ovidiu Veresezan; Idriss Troussier; Alexis Lacout; Sarah Kreps; Sophie Maillard; Aude Toulemonde; Pierre-Yves Marcy; Florence Huguet; Juliette Thariat
Journal:  Jpn J Radiol       Date:  2016-12-01       Impact factor: 2.374

3.  Neck dissection followed by definitive radiotherapy for small upper aerodigestive tract squamous cell carcinoma, with advanced neck disease: an alternative treatment strategy.

Authors:  Ashok M Shenoy; T Shiva Kumar; V Prashanth; Purushotham Chavan; Rajshekar Halkud; Linu Jacob; K Govind Babu; G Lokesh; Tanveer Pasha; Rekha V Kumar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-01-06

4.  Up-front neck dissection followed by chemoradiotherapy for T1-T3 hypopharyngeal cancer with advanced nodal involvement.

Authors:  Mitsuo P Sato; Naoki Otsuki; Mutsukazu Kitano; Kazuki Ishikawa; Kaoru Tanaka; Takayuki Kimura; Katsumi Doi
Journal:  Head Neck       Date:  2021-09-22       Impact factor: 3.821

5.  Predicting outcomes in cervical cancer: a kinetic model of tumor regression during radiation therapy.

Authors:  Zhibin Huang; Nina A Mayr; William T C Yuh; Simon S Lo; Joseph F Montebello; John C Grecula; Lanchun Lu; Kaile Li; Hualin Zhang; Nilendu Gupta; Jian Z Wang
Journal:  Cancer Res       Date:  2010-01-12       Impact factor: 12.701

6.  Initial Experience of Intentional Internal High-Dose Policy Volumetric Modulated Arc Therapy of Neck Lymph Node Metastases ≥ 2 cm in Patients With Head and Neck Squamous Cell Carcinoma.

Authors:  Tairo Kashihara; Satoshi Nakamura; Naoya Murakami; Kimiteru Ito; Yoshifumi Matsumoto; Kenya Kobayashi; Go Omura; Taisuke Mori; Yoshitaka Honma; Yuko Kubo; Hiroyuki Okamoto; Kana Takahashi; Koji Inaba; Kae Okuma; Hiroshi Igaki; Yuko Nakayama; Ken Kato; Fumihiko Matsumoto; Seiichi Yoshimoto; Jun Itami
Journal:  Front Oncol       Date:  2021-04-27       Impact factor: 6.244

Review 7.  Controversies in management of the neck in head and neck cancer.

Authors:  Madhur Garg; Jonathan J Beitler
Journal:  Curr Treat Options Oncol       Date:  2004-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.